Vaccinal prevention of infectious diseases in adults
https://doi.org/10.22625/2072-6732-2018-10-2-5-16
Abstract
The results of foreign and Russian author`s researches about immunization of adult population are presented in article. The analysis of the vaccinal prevention state of infectious diseases in adults in different countries of the world (national guidance on adults immunization, coverage of preventive vaccinations, financing mechanisms) is given. The tasks of improving immunization in adult population of Russia are defined.
About the Authors
N. I. Briko
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Moscow, Russia
Russian Federation
Moscow, Russia
I. V. Feldblium
Perm State Medical University named after cademician E.A. Wagner
Russian Federation
Perm, Russia
Russian Federation
Perm, Russia
K. A. Subbotina
Perm State Medical University named after cademician E.A. Wagner
Russian Federation
Perm, Russia
Russian Federation
Perm, Russia
A. V. Bikmieva
Perm State Medical University named after cademician E.A. Wagner
Russian Federation
Perm, Russia
Russian Federation
Perm, Russia
N. N. Tsapkova
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Moscow, Russia
Russian Federation
Moscow, Russia
E. A. Boiko
First Moscow State Medical University named after I.M. Sechenov
Сenter for strategic planning and management of biomedical risks to health
Russian Federation
Moscow, Russia
Russian Federation
Moscow, Russia
References
1. Wu, LA., Kanitz, E., Crumly, J. et al. Int J Public Health (2013) 58: 865. https://doi.org/10.1007/s00038-012-0438-x
2. Otto W, Mankertz A, Santibanez S, et al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill. 2010;15:21–4.
3. Monsel G, Rapp C, Duong TA, et al. Measles in adults: an emerging disease not sparingmedical staff. Ann Dermatol. Venereol.2011;138:107–10.
4. Barret AS, Ryan A, Breslin A, et al. Pertussis outbreak in northwest Ireland, January–June 2010. Euro Surveill. 2010;15:3–7.
5. Worldwide report about aging and health. World Health Organization. 2016. Ssylka aktivna na 22.01.2018 g. (In Russ.)] http://apps.who.int/iris/bitstream/10665/186463/10/9789244565049_rus.pdf?ua=1
6. Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the antivaccine movement, and vaccinomics. Vaccine 2009;27(25–26):3240–4.
7. United Nations Department of Economic and Social Affairs. Population Division. World population ageing 2015 (ST/ESA/SER.A/390). 2015. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2015_Rep ort.pdf.Zugegriffen:20.2.2017.
8. Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti- vaccine movement, and vaccinomics. Vaccine. 2009;27:3240–4. https://doi:10.1016/j.vaccine.2009.01.069.
9. Pham H, Geraci SA, Burton MJ., CDC Advisory Committeeon Immunization Practices. Adult immunizations: update on recommendations. Am J Med. 2011;124:698–701. https://doi.10.1016/j.amjmed.2010.07.032.
10. Kristensen M, van Lier A, Eilers R, et al. Burden of four vaccine preventable diseases in older adults. Vaccine. 2016;34:942–9.
11. Hutt, H.J., Bennerscheidt, P., Thiel, B. et al. Med Klin (2010) 105: 802. https://doi.org/10.1007/s00063-010-1137-0
12. Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM, et al. Combined reduced-antigen content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Vaccine 2005;23:3657-67.
13. Van Damme P, Burgess M. Immunogenicity of a combined diphtheria-tetanus- acellular pertussis vaccine in adults. Vaccine.2004;22:305–8.
14. Hoel T, Wolter JM, Schuerman LM. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults. Eur JEmergMed.2006;13:67–71.
15. Vellinga A, Van DP, Joossens E, et al. Response to diphtheria booster vaccination in healthy adults: vaccine trial. BMJ. 2000;320:217.
16. Weinberger B. Adult vaccination against tetanus and diphtheria: the European perspective. Clinical & Experimental Immunology. 2017;187:93–9. https://doi:10.1111/cei.12822.
17. Wicker S, Maltezou HC. Vaccine-preventable diseases in Europe: where do we stand? Expert Rev Vaccines. 2014; https://doi: 10.1586/14760584.2014.933077.
18. Di Giovine P, Kafatos G, Nardone A, et al. Comparative seroepidemiology of diphtheria in six European countries and Israel. Epidemiol Infect.2013;141:132–42.
19. Maksimova N.M., Yakimova T.N., Markina S.S., Yatskovskii K.A., Adugyuzelov S.E. Diphtheria in Russia in XXI century. Epidemiologiya i vaktsinoprofilaktika. 2017; 5(96): 4-15. (In Russ.)
20. Kunze, U. & Groman, E. Vienna Med Wochenschr (2017). https://doi.org/10.1007/s10354-017-0598-7
21. Measles in Russia: problems of liquidation. Pod red. Onishchenko G.G., Popovoi A.Yu., Aleshkina V.A. M.: Izdatel’stvo Dinastiya; 2017. (In Russ.)
22. Maltezou HC., Ftika L, Theodoridou M. Nosocomial pertussis in neonatal units. Journal of Hospital Infection; 85 (2013): 243-248
23. Fel’dblyum I.V., Subbotina K.А., Nikolaeva А.M., Sosnina O.YU., Vyaznikova T.V., Markovich N.I. The situation about diphtheria, tetanus and pertussis immunity in adults in the modern conditions. Rossijskij immunologicheskij zhurnal. 2017; 11(20) № 1: 64-69
24. A. Calugar, IR, Ortega-Sanchez, T, Tiwari, L, Oakes, JA, Jahre, TV. Murphy Nosocomial pertussis: cost of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis. 2006; 42: 981–988.
25. Greer, AL, Fisman, DN. Keeping vulnerable children safe from pertussis: preventing nosocomial pertussis transmission in the neonatal intensive care unit Infect Control. HospEpidemiol. 2009; 30 (11) (2009), pp. 1084–1089
26. Welte, T, Torres, A, Nathwani, D. Clinical and economic burden of community- acquired pneumonia among adults in Europe. Thorax. 2012; 67: 71-79. https://doi:10.1136/thx.2009.129502
27. Bilichenko T.N., Argunova A.N., Antonova O.A., Solov’ev K.I., Gladin S.A., Nikitina N.N., Lyamin A.V., Chigishchev A.P., Puchkina N.E. The frequency of pneumococcal pneumonia in adult patients of therapeutic hospitals in the three territories of the Russian Federation. Pul’monologiya. 2013;4: 29-36. (In Russ.)
28. Leon Peto, Behzad Nadjm, Peter Horby, Ta Thi Dieu Ngan, Rogier van Doorn, Nguyen Van Kinh, Heiman F. L. Wertheim. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014; 108: 326–337. https://doi:10.1093/trstmh/tru058
29. Pneumococcal vaccines: document of position WHO. 2012. Ezhenedel’nyi epidemiologicheskii byulleten’ 6 aprelya 2012 g., 87-i god № 14, 2012, 87, 129-144. Ssylka aktivna na 22.01.2018 g. (In Russ.)
30. Kimberly M. Shea, John Edelsberg, Derek Weycker, Raymond A. Farkouh, David R. Strutton, Stephen I. Pelton. Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions. Open Forum Infect Dis. 2014; May 27;1(1):ofu024. https://doi.org/10.1093/ofid/ofu024
31. van Hoek A et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect. 2012; 65(1): 17-24. https://doi:10.1016/j.jinf.2012.02.017
32. S. Jain, W.H. Self, R.G. Wunderink, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. The New England Journal of Medicine. 2015;373:415- 427. https://doi:10.1056/NEJMoa1500245
33. WHO vaccine-preventable diseases: monitoring system. 2017 global summary. Доступно на: http://apps.who.int/immunizationmonitoring/globalsummary/schedules
34. National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases. Pneumococcal Vaccination. Доступно на: https://www.cdc.gov/pneumococcal/vaccination.html
35. Home Australian Immunisation Handbook The National Immunisation Program/ Доступно на: http://www.health.gov.au/internet/immunise/publishing.nsf/Content/national- immunisation-program-schedule
36. Vaccine Recommendations and Guidelines of the ACIP. Доступно на: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html
37. Falkenhorst G et al Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany, Bundesgesundheitsbl 2016;59:1623–1657
38. Houseman C, Hughes GJ, Chapman KE, et al. Increased Invasive Pneumococcal Disease, North East England, UK. Emerging Infectious Diseases. 2017;23(1):122-126. doi:10.3201/eid2301.160897.
39. Epidemiology, clinic and prevention of pneumococcal infection. Mezhdistsiplinarnoe uchebnoe posobie dlya vrachey. Pod red. Briko N.I. M.: Izdatelstvo Remedium Povolzhe; 2017. (In Russ.)
40. World Health Organization (WHO). Fact sheet Influenza No. 211. 2009. http://www.who.int/mediacentre/factsheets/2003/fs211/en.
41. Muller D, Szucs TD. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 2007;35(5):308–19.
42. Johnson RW, Alvarez-Pasquin M, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. TherAdv Vaccines. 2015;4:109–20. https://doi:10. 1177/2051013615599151.
43. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV- exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166.
44. MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep 2016;65:1189– 1194. DOI: http://dx.doi.org/10.15585/mmwr.mm6543a3
45. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Jul 1;59(1):144.
46. Canadian Immunization Guide: Part 3 – Vaccination of Specific Populations. Доступно на: https://www.canada.ca/en/public-health/services/publications/healthy- living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-8- immunization-immunocompromised-persons.html#p3c7t5
47. The Australian Immunisation Handbook 10th Edition. Доступно на: http://www.immunise.health.gov.au/internet/immunise/ publishing.nsf/content/Handbook10-home
48. Immunisation Handbook 2017. Доступно на: www.health.govt.nz/system/files/documents/publications/immunisation-handbook-2017-may17-v2.html
49. van Ravenhorst MB, Bijlsma MW, van Houten MA, Struben VMD, Anderson AS, Eiden J, et al. Meningococcal carriage in Dutch adolescents and young adults; a cross- sectional and longitudinal cohort study. Clin Microbiol Infect. 2017 Aug;23(8):573.e1-573.e7. doi: 10.1016/j.cmi.2017.02.008.
50. Wiedermann, U., Sitte, H.H., Burgmann, H. et al. Wien Klin Wochenschr (2016) 128(Suppl 4): 337. https://doi.org/10.1007/s00508-016-1033-6
51. O’Flanagan D, Cotter S, Mereckiene J. Finalised report on the decision making process, modalities of implementation and current country status for the introduction of human papillomavirus and rotavirus vaccination into national immunisationprogrammes in Europe. VENICE II Work package. No. 3; 2010. Available from: http://venice.cineca.org/Venice2 WP3 Report December2010.pdf [cited September 2011].
52. Kollaritsch H, Chmelik V, Dontsenko I, Grzeszczuk A, Kondrusik M, Usonis V, et al. The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: report from a meeting of experts convened to discuss TBE in their region. Vaccine 2011;29(28):4556–64.
53. Stefanoff P, Polkowska A, D’Ancona F, Giambi C, Levy-Bruhl D, O’Flanagan D, et al. Tick-borne encephalitis surveillance systems and vaccination recommendations in UE/EEA, 2009. Collaboration between VENICE II project and ECDC. Available from: http://venice.cineca.org/final report TBE 19-01-2011.pdf [cited September 2011].
54. Stefanoff P, Polkowska A, Giambi C, Levy-Bruhl D, O’Flanagan D, Dematte L, et al. Reliable surveillance of tickborne encephalitis in European countries is necessary to improve the quality of vaccine recommendations. Vaccine 2011;29(6):1283–8.
55. Work and employment in Russia. 2017: Stat.sb./Rosstat-T78 M., 2017 (In Russ.)
56. Kostinov M.P., Lukachev I.V. The abilitiies of improving vaccinal prevention in modern Russia. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2016; 4: 60-65. (In Russ.)
57. VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points, Kanitz EE, Wu LA, Giambia C, et al. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine. 2012;30:5222–8.
58. European Federation of Internal Medicine ADVICE Working Group, Ozisik L, Tanriover TM, Rigby S. ADVICE for ahealthier life: adult vaccinationcampaign inEurope.Eur J. InternMed. 2016;33:14–20.
59. Wu LA, Kanitz E, Crumly J, et al. Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage. Int J Public Health. 2013;58:865–74. https://doi.org/10.1007/s00038-012-0438-x.
60. Recommendations from the National Vaccine Advisory Committee: Standards for Adult Immunization Practice. Public Health Rep. 2014 Mar-Apr; 129(2): 115–123. doi: 10.1177/003335491412900203
61. Baranov А.А., Briko N.I., Namazova-Baranova L.S., Fedoseenko M.V. Legal and ethical basis for informed consent to vaccination in Russia: the necessity of changing approach. Pediatricheskaya farmakologiya. 2016; 13(2): 116-130. (In Russ.)
Review
For citations:
Briko N.I., Feldblium I.V., Subbotina K.A., Bikmieva A.V., Tsapkova N.N., Boiko E.A. Vaccinal prevention of infectious diseases in adults. Journal Infectology. 2018;10(2):5-16. (In Russ.) https://doi.org/10.22625/2072-6732-2018-10-2-5-16
Views:
2142
.png)
.png)
Email this article 